Dyne Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Dyne Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2024.
  • Dyne Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $10.5M, a 82.8% increase year-over-year.
  • Dyne Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $45.9M, a 130% increase year-over-year.
  • Dyne Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $45.9M, a 130% increase from 2023.
  • Dyne Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $20M, a 31.6% increase from 2022.
  • Dyne Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.2M, a 13.5% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $45.9M +$25.9M +130% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $20M +$4.79M +31.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $15.2M -$2.36M -13.5% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $17.5M +$11M +166% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 $6.59M +$6.57M +25250% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $26K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.